Ligand id: 5469

Name: stiripentol

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 38.69
Molecular weight 234.13
XLogP 3.16
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
May be used as an adjunct in the treatment of epilepsy. In particular, this drug is indicated for the treatment of severe myoclonic epilepsy in infancy (SMEI or Dravet’s syndrome).
Mechanism Of Action and Pharmacodynamic Effects
Stiripentol appears to increase inhibitory GABA transmission, by increasing the duration of opening of GABAA channels. It may also improve the effectiveness of other anticonvulsants.
External links